Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: Results from the LIBERTY study
Journal of Neurology, Neurosurgery & Psychiatry | Dec 02, 2021
Journal of Neurology, Neurosurgery & Psychiatry | Dec 02, 2021